1.75

4.37% -0.08

Iovance Biotherapeutics Inc (IOVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IOVA? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.83

Offen:

$1.82

24-Stunden-Volumen:

7.66M

Relative Volume:

0.59

Marktkapitalisierung:

$584.38M

Einnahmen:

$32.77M

Nettoeinkommen (Verlust:

$-440.22M

KGV:

-1.0479

EPS:

-1.67

Netto-Cashflow:

$-400.48M

1W Leistung:

-1.69%

1M Leistung:

-50.84%

6M Leistung:

-81.22%

1J Leistung:

-80.56%

1-Tages-Spanne:

$1.71

$1.828

1-Wochen-Bereich:

$1.70

$1.87

52-Wochen-Spanne:

$1.6385

$12.51

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Firmenname

Iovance Biotherapeutics Inc

Sektor

Healthcare (1170)

Branche

Biotechnology (667)

Telefon

(650) 260-7120

Adresse

825 INDUSTRIAL ROAD, SAN CARLOS

Mitarbeiter

838

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

IOVA's Discussions on Twitter

Vergleichen Sie IOVA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IOVA Iovance Biotherapeutics Inc	1.75	594.40M	32.77M	-440.22M	-400.48M	-1.67
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-16	Herabstufung	UBS	Buy → Neutral
2025-05-12	Herabstufung	Truist	Buy → Hold
2025-05-09	Herabstufung	Citizens JMP	Mkt Outperform → Mkt Perform
2024-10-24	Eingeleitet	UBS	Buy
2024-07-29	Herabstufung	Piper Sandler	Overweight → Neutral
2023-11-20	Eingeleitet	Goldman	Buy
2023-09-18	Bestätigt	Barclays	Overweight
2023-05-30	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-27	Fortgesetzt	Wells Fargo	Equal Weight
2023-01-27	Hochstufung	Piper Sandler	Neutral → Overweight
2022-12-09	Herabstufung	Goldman	Buy → Neutral
2022-10-31	Eingeleitet	Guggenheim	Neutral
2022-08-18	Fortgesetzt	Wells Fargo	Equal Weight
2022-01-28	Hochstufung	Stifel	Hold → Buy
2021-12-07	Fortgesetzt	Cowen	Outperform
2021-06-10	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2021-05-20	Herabstufung	Piper Sandler	Overweight → Neutral
2021-05-19	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2021-05-19	Herabstufung	Stifel	Buy → Hold
2021-05-03	Eingeleitet	Truist	Buy
2021-04-16	Eingeleitet	Goldman	Buy
2021-03-08	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-12-15	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-10-06	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-04-22	Eingeleitet	Mizuho	Buy
2020-03-04	Eingeleitet	Barclays	Overweight
2020-02-26	Bestätigt	H.C. Wainwright	Buy
2020-02-26	Bestätigt	Oppenheimer	Outperform
2019-12-18	Eingeleitet	JMP Securities	Mkt Outperform
2019-10-01	Eingeleitet	Stifel	Buy
2019-04-29	Eingeleitet	Piper Jaffray	Overweight
2019-02-28	Bestätigt	Chardan Capital Markets	Buy
2019-02-07	Eingeleitet	Robert W. Baird	Outperform
2018-12-31	Fortgesetzt	B. Riley FBR	Buy
2018-07-06	Bestätigt	Chardan Capital Markets	Buy
2018-04-10	Hochstufung	B. Riley FBR, Inc.	Neutral → Buy
2018-03-13	Bestätigt	B. Riley FBR, Inc.	Neutral
2018-02-23	Herabstufung	B. Riley FBR, Inc.	Buy → Neutral
2018-01-25	Bestätigt	H.C. Wainwright	Buy
2017-11-01	Bestätigt	B. Riley FBR, Inc.	Buy

Alle ansehen

Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten

07:05 AM

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky to Join Class Action Before July 14, 2025 - ACCESS Newswire

07:05 AM

May 31, 2025

IOVA LAWSUIT ALERT: Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. InvestorsLead Plaintiff Deadline July 14, 2025 - ACCESS Newswire

May 31, 2025

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA) - TradingView

May 31, 2025

May 30, 2025

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 30, 2025

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - Eastern Progress

May 30, 2025

IOVA DEADLINE REMINDER: Iovance Biotherapeutics, Inc. Investors May Be Able to Recover LossesContact BFA Law by July 14 Class Action Deadline - ACCESS Newswire

May 30, 2025

Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance ... - Eagle-Tribune

May 30, 2025

Robbins LLP Reminds IOVA Stockholders That a Class Action - GlobeNewswire

May 30, 2025

Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance Biotherapeutics, Inc. Alleging the Company Misled Investors Regarding its Business Prospects - TradingView

May 30, 2025

Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

May 30, 2025

IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - marketscreener.com

May 30, 2025

Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA)July 14, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire

May 30, 2025

May 29, 2025

Investors in Iovance Biotherapeutics, Inc. Should Contact The Gross Law Firm Before July 14, 2025 to Discuss Your Rights – IOVA - TradingView

May 29, 2025

Scott+Scott Attorneys at Law LLP Continues to Remind - GlobeNewswire

May 29, 2025

Scott+Scott Attorneys at Law LLP Continues to Remind Investors an Action Has Been Filed Against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - TradingView

May 29, 2025